AbTis

About:

AbTis is a biotechnology company that provides antibody-drug conjugation technology and solubilization.

Top Investors: Korea Development Bank, Aju IB Investment, Timepolio Asset Management, Stonebridge Capital, K2 Investment Partners

Description:

Total Funding Amount:

15B KRW

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Gunpo, Kyonggi-do, South Korea

Founded Date:

2016-08-01

Contact Email:

info(AT)abtis.co.kr

Founders:

Number of Employees:

11-50

Last Funding Date:

2021-02-02

IPO Status:

Private

Industries: